EU Regulator Finds ‘Possible Link’ Between Astra Shot, Clots

The European Medicines Agency confirms that the AstraZeneca vaccine's benefits in preventing COVID-19 outweigh the risks of side effects. Despite rare cases of blood clotting, the vaccine is effective in reducing severe disease and hospitalizations. An expert group found no specific risk factors for these side effects, which may be an immune response similar to heparin-induced thrombocytopenia. The EMA is working with EU authorities to ensure risks are communicated to healthcare professionals. Ongoing monitoring of vaccine safety and effectiveness will continue, with updates provided as needed.

What is a plausible explanation for the rare side events associated with the Astra Zeneca vaccine?

Why is it important for vaccinated people and healthcare professionals to be aware of the signs and symptoms of unusual blood clotting disorders?